Granules Pharma earns USFDA tentative nod for Attention Deficit Hyperactivity Disorder drug
Hyderabad: Granules Pharmaceuticals, a wholly owned subsidiary of Granules India, has received tentative approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for…